# clm_4585DB96888D

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: 2,048,200,000 United States dollar  
valid_from: 2026-09-30  
valid_to: null  
published: 2026-10-30  
recorded: 2026-11-08  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly operating income: 2,048,200,000 United States dollar", as of 2026-09-30. Claim clm_4585DB96888D, https://asof.is/claim/clm_4585DB96888D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm (primary, SEC EDGAR 10-Q Q3 FY2026, published 2026-10-30)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,293,500,000 United States dollar | valid 2026-06-30 to 2026-09-30 | conf 0.95 | superseded | superseded_by [clm_4585DB96888D](/claim/clm_4585DB96888D.md) | [clm_2721EF4559B5](/claim/clm_2721EF4559B5.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.